Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2026-05-13 @ 6:02 PM
Study NCT ID:
NCT05391750
Status:
RECRUITING
Last Update Posted:
2025-01-24
First Post:
2022-04-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Venetoclax and Tocilizumab for the Treatment of Patients With Relapsed or Refractory t(11;14) Multiple Myeloma
Sponsor:
Emory University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
STUDY00002448
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |